{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:46:16Z","timestamp":1777535176710,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.toxicon.2021.04.017","type":"journal-article","created":{"date-parts":[[2021,4,24]],"date-time":"2021-04-24T10:59:43Z","timestamp":1619261983000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Development and characterization of human single chain antibody against Iranian Macrovipera lebetina snake venom"],"prefix":"10.1016","volume":"197","author":[{"given":"Ayda Hassanzadeh","family":"Eskafi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran Pooshang","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahdi","family":"Behdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montarop","family":"Yamabhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-8666","authenticated-orcid":false,"given":"Delavar","family":"Shahbazzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Kazemi-Lomedasht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2021.04.017_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/1547691X.2018.1526234","article-title":"Oligoclonal selection of nanobodies targeting vascular endothelial growth factor","volume":"16","author":"Ahadi","year":"2019","journal-title":"J. Immunot."},{"key":"10.1016\/j.toxicon.2021.04.017_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/cgt.2016.76","article-title":"Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization","volume":"24","author":"Alirahimi","year":"2017","journal-title":"Canc. Gene Ther."},{"key":"10.1016\/j.toxicon.2021.04.017_bib3","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.bbagen.2018.08.019","article-title":"Nanobodies as novel therapeutic agents in envenomation","volume":"1862","author":"Alirahimi","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.toxicon.2021.04.017_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0009-9120(02)00343-0","article-title":"Phage display technology: clinical applications and recent innovations","volume":"35","author":"Azzazy","year":"2002","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.toxicon.2021.04.017_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15569543.2016.1244552","article-title":"Development of a recombinant camelid specific diabody against the heminecrolysin fraction of Hemiscorpius lepturus scorpion","volume":"36","author":"Bagheri","year":"2017","journal-title":"Toxin Rev."},{"key":"10.1016\/j.toxicon.2021.04.017_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/antib8020028","article-title":"David vs. Goliath: the structure, function, and clinical prospects of antibody fragments","volume":"8","author":"Bates","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.toxicon.2021.04.017_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-1759(87)90187-6","article-title":"Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay","volume":"100","author":"Beatty","year":"1987","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.toxicon.2021.04.017_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40409-016-0074-7","article-title":"Paths to the discovery of antivenom serotherapy in France","volume":"22","author":"Bochner","year":"2016","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2021.04.017_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/abio.1996.0241","article-title":"Filamentous phage display of oligopeptide libraries","volume":"238","author":"Burritt","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.toxicon.2021.04.017_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.toxicon.2014.05.017","article-title":"A neutralizing recombinant single chain antibody, scFv, against BaP1, A PI hemorrhagic metalloproteinase from Bothrops asper snake venom","volume":"87","author":"Castro","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.04.017_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0165-022X(02)00002-7","article-title":"An improved method for isolation of anti-viper venom antibodies from chicken egg yolk","volume":"51","author":"Devi","year":"2002","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.toxicon.2021.04.017_bib12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.tibtech.2010.05.001","article-title":"Generating recombinant antibodies to the complete human proteome","volume":"28","author":"D\u00fcbel","year":"2010","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib13","doi-asserted-by":"crossref","DOI":"10.3791\/253","article-title":"Transformation of plasmid DNA into E. coli using the heat shock method","author":"Froger","year":"2007","journal-title":"JoVE: JoVE"},{"key":"10.1016\/j.toxicon.2021.04.017_bib14","first-page":"1738","article-title":"Biological activity of a lectin-like protein purified from Vipera lebetina venom","volume":"12","author":"Gasmi","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.04.017_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.biologicals.2011.02.005","article-title":"Antivenoms for the treatment of snakebite envenomings: the road ahead","volume":"39","author":"Guti\u00e9rrez","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.toxicon.2021.04.017_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jprot.2009.01.008","article-title":"Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming","volume":"72","author":"Guti\u00e9rrez","year":"2009","journal-title":"Journal of proteomics"},{"key":"10.1016\/j.toxicon.2021.04.017_bib17","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0603653103","article-title":"Isolation of anti-CD22 Fv with high affinity by Fv display on human cells","volume":"103","author":"Ho","year":"2006","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.toxicon.2021.04.017_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.toxicon.2016.11.247","article-title":"Identification of the immunogenic epitopes of the whole venom component of the Hemiscorpius lepturus scorpion using the phage display peptide library","volume":"124","author":"Jahdasani","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.04.017_bib19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1073\/pnas.41.11.849","article-title":"The natural-selection theory of antibody formation","volume":"41","author":"Jerne","year":"1955","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.toxicon.2021.04.017_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s40409-018-0175-6","article-title":"Morphometric characteristics and seasonal proximity to water of the Cypriot blunt-nosed viper Macrovipera lebetina lebetina (Linnaeus, 1758)","volume":"24","author":"Jestrzemski","year":"2018","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2021.04.017_bib21","series-title":"Snakebite Nephrotoxicity in Asia, Seminars in Nephrology","first-page":"363","author":"Kanjanabuch","year":"2008"},{"key":"10.1016\/j.toxicon.2021.04.017_bib22","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.toxicon.2021.04.017_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/mab.2016.0001","article-title":"Production and characterization of novel camel single domain antibody targeting mouse vascular endothelial growth factor","volume":"35","author":"Kazemi-Lomedasht","year":"2016","journal-title":"Monoclon. Antibodies Immunodiagn. Immunother."},{"key":"10.1016\/j.toxicon.2021.04.017_bib24","first-page":"260","article-title":"Design of a humanized anti vascular endothelial growth factor nanobody and evaluation of its in vitro function","volume":"21","author":"Kazemi-Lomedasht","year":"2018","journal-title":"Iranian journal of basic medical sciences"},{"key":"10.1016\/j.toxicon.2021.04.017_bib25","first-page":"489","article-title":"In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies","volume":"20","author":"Kazemi-Lomedasht","year":"2017","journal-title":"Iranian journal of basic medical sciences"},{"key":"10.1016\/j.toxicon.2021.04.017_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.toxicon.2019.10.006","article-title":"Development of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venom","volume":"171","author":"Kazemi-Lomedasht","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.04.017_bib27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jmbi.1999.3444","article-title":"Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides","volume":"296","author":"Knappik","year":"2000","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/clinchem\/45.7.942","article-title":"Human anti-animal antibody interferences in immunological assays","volume":"45","author":"Kricka","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.toxicon.2021.04.017_bib29","first-page":"1","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.toxicon.2021.04.017_bib30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrd3756","article-title":"Antibody-enabled small-molecule drug discovery","volume":"11","author":"Lawson","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.toxicon.2021.04.017_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/toxins10060236","article-title":"Basics of antibody phage display technology","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2021.04.017_bib32","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.celrep.2018.09.090","article-title":"Intrinsic nucleotide preference of diversifying base editors guides antibody ex vivo affinity maturation","volume":"25","author":"Liu","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.toxicon.2021.04.017_bib33","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0140-6736(00)04868-6","article-title":"Tackling venomous snake bites worldwide","volume":"357","author":"McNamee","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2021.04.017_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.toxicon.2016.02.004","article-title":"The first report on coagulation and phospholipase A2 activities of Persian Gulf lionfish, Pterois russelli, an Iranian venomous fish","volume":"113","author":"Memar","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.04.017_bib35","doi-asserted-by":"crossref","first-page":"199","DOI":"10.15171\/bi.2017.23","article-title":"Osmotic conditions could promote scFv antibody production in the Escherichia coli HB2151","volume":"7","author":"Mesgari-Shadi","year":"2017","journal-title":"Bioimpacts: BI"},{"key":"10.1016\/j.toxicon.2021.04.017_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S1678-91992009000100002","article-title":"Snake antivenoms: adverse reactions and production technology","volume":"15","author":"Morais","year":"2009","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2021.04.017_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1742-7843.2008.00322.x","article-title":"Expression of human recombinant antibody fragments capable of partially inhibiting the phospholypase activity of Crotalus durissus terrificus venom","volume":"105","author":"Oliveira","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6750-9-6","article-title":"A compact phage display human scFv library for selection of antibodies to a wide variety of antigens","volume":"9","author":"Pansri","year":"2009","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib39","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/nbt1204-1513","article-title":"Recombinant protein therapeutics\u2014success rates, market trends and values to 2010","volume":"22","author":"Pavlou","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.toxicon.2016.01.062","article-title":"Human scFv antibodies (Afribumabs) against Africanized bee venom: advances in melittin recognition","volume":"112","author":"Pessenda","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.04.017_bib41","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.3389\/fimmu.2019.01598","article-title":"History of envenoming therapy and current perspectives","volume":"10","author":"Pucca","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib42","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0041-0101(94)90087-6","article-title":"Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production","volume":"32","author":"Rojas","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.04.017_bib43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/dta.2693","article-title":"Development of a mono\u2010specific anti\u2010VEGF bivalent nanobody with extended plasma half\u2010life for treatment of pathologic neovascularization","volume":"12","author":"Sadeghi","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.toxicon.2021.04.017_bib44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/71958","article-title":"Exploiting recombination in single bacteria to make large phage antibody libraries","volume":"18","author":"Sblattero","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib45","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.toxicon.2009.08.010","article-title":"Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP\u00ae) for the treatment of viper envenoming in sub-Saharan Africa","volume":"55","author":"Segura","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2021.04.017_bib46","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1073\/pnas.95.11.6157","article-title":"Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens","volume":"95","author":"Sheets","year":"1998","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.toxicon.2021.04.017_bib47","series-title":"Phage Display Technology, a Wide Range of Applications","author":"Souriau","year":"1998"},{"key":"10.1016\/j.toxicon.2021.04.017_bib48","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bbagen.2006.04.008","article-title":"Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom","volume":"1760","author":"Tamarozzi","year":"2006","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.toxicon.2021.04.017_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-3083.2003.01189.x","article-title":"Clonal analysis of a human antimouse antibody (HAMA) response","volume":"57","author":"Thorpe","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib50","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nbt0396-309","article-title":"Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library","volume":"14","author":"Vaughan","year":"1996","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2021.04.017_bib51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1423-0410.2000.7820072.x","article-title":"Introduction to antibody engineering and phage display","volume":"78","author":"Watkins","year":"2000","journal-title":"Vox Sang."},{"key":"10.1016\/j.toxicon.2021.04.017_bib52","series-title":"Study on development of Vipera lebetina snake anti-venom in chicken egg yolk for passive immunization","first-page":"2734","volume":"11","author":"Zolfagharian","year":"2015"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:18:37Z","timestamp":1758575917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010121001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":52,"alternative-id":["S0041010121001276"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.04.017","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of human single chain antibody against Iranian Macrovipera lebetina snake venom","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}